MARATTO

article · Journal of Liposome Research

Biophysical and biological evaluation of free and liposomal doxorubicin and β-carotene reveals enhanced therapeutic selectivity in MCF-7 breast cancer cells

2026Benha University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

≈ 20 µg/mL). Overall, these findings suggest that liposomal co-delivery of β-carotene and doxorubicin may enhance therapeutic efficacy while potentially reducing off-target toxicity.

Research topics

  • Nanoparticle-Based Drug Delivery
  • Antioxidant Activity and Oxidative Stress
  • Chemotherapy-induced cardiotoxicity and mitigation

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1080/08982104.2026.2671264

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.